Imperial College London

ProfessorDuncanGeddes

Faculty of MedicineNational Heart & Lung Institute

Professor in Respiratory Medicine
 
 
 
//

Contact

 

+44 (0)20 7351 8182d.geddes

 
 
//

Location

 

Royal BromptonRoyal Brompton Campus

//

Summary

 

Summary

Duncan Geddes is Professor in Respiratory Medicine at the National Heart and Lung Institute, Consultant Physician at the Royal Brompton Hospital and Honorary Consultant at the Royal Marsden Hospital.

Professor Geddes was an undergraduate at Magdelene College, Cambridge University, reading Natural Sciences, before moving to King's College and Westminster Hospital Medical School where he studied medicine. Professor Geddes subsequently held a range of clinical training posts, including acting as Senior House Office for Professor Dame Margaret Turner Warwick at the Royal Brompton Hospital. He was appointed as Professor of Respiratory Medicine at Imperial College in 1996. He is currently Head of Lungs at the Royal Brompton Hospital and joint head of the lung cancer programme at the Royal Marsden, Royal Brompton and Chelsea & Westminster hospitals.

Professor Geddes' other appointments include numerous roles at the National Asthma Campaign (now Asthma UK) including acting as Chairman of the Council of Trustees (1994-2004), President of the British Thoracic Society (2000-2001) and has been a Trustee of the Garfield Western Charitable Trust since 2000.

During his career he has published over 300 papers, written many book chapters and edited leading textbooks in his specialist interest area of respiratory medicine and cystic fibrosis.

Publications

Journals

Hopkinson NS, Kemp SV, Toma TP, et al., 2011, Atelectasis and survival after bronchoscopic lung volume reduction for COPD, European Respiratory Journal, Vol:37, ISSN:0903-1936, Pages:1346-1351

Fidler KJ, Hilliard TN, Bush A, et al., 2009, Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism, Thorax, Vol:64, ISSN:0040-6376, Pages:150-155

Geddes D, 2008, Segregation is not good for patients with cystic fibrosis., J R Soc Med, Vol:101 Suppl 1, ISSN:0141-0768, Pages:S36-S38

Larsen MDB, Griesenbach U, Goussard S, et al., 2008, Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli, Gene Therapy, Vol:15, ISSN:0969-7128, Pages:434-442

Conference

Hopkinson NS, Kemp SV, Toma TP, et al., 2010, ATELECTASIS FOLLOWING BRONCHOSCOPIC LUNG VOLUME REDUCTION (BLVR) IS ASSOCIATED WITH IMPROVED SURVIVAL IN COPD, British-Thoracic-Society-Winter-Meeting 2010, B M J PUBLISHING GROUP, Pages:A137-A137, ISSN:0040-6376

More Publications